| Pioglitazone | Approved Investigational | PLIN2 | 123 |
upregulated | pioglitazone results in increased expression of PLIN2 mRNA | 9p22.1 | |
| Pioglitazone | Approved Investigational | PPARA | 5465 |
upregulated | pioglitazone results in increased expression of PPARA mRNA | 22q13.31 | |
| Pioglitazone | Approved Investigational | PPARD | 5467 |
upregulated | pioglitazone results in increased expression of PPARD mRNA | 6p21.31 | |
| Pioglitazone | Approved Investigational | PPARG | 5468 |
upregulated | pioglitazone results in increased expression of PPARG mRNA | 3p25.2 | |
| Pioglitazone | Approved Investigational | PPARG | 5468 |
upregulated | pioglitazone results in increased expression of PPARG mRNA alternative form | 3p25.2 | |
| Pioglitazone | Approved Investigational | SERPINE1 | 5054 |
upregulated | pioglitazone results in increased expression of SERPINE1 mRNA | 7q22.1 | |
| Pioglitazone | Approved Investigational | SOD1 | 6647 |
upregulated | pioglitazone results in increased expression of SOD1 mRNA | 21q22.11 | |
| Pioglitazone | Approved Investigational | TFAM | 7019 |
downregulated | pioglitazone results in decreased expression of TFAM mRNA | 10q21.1 | |
| Piperazine | Approved Vet Approved Withdrawn | IL2 | 3558 |
downregulated | piperazine analog results in decreased expression of IL2 mRNA | 4q27 | |
| Piperine | Investigational | ABCB1 | 5243 |
upregulated | piperine results in increased expression of ABCB1 mRNA | 7q21.12 | |
| Piperine | Investigational | CSF2 | 1437 |
downregulated | piperine results in decreased expression of CSF2 mRNA | 5q31.1 | |
| Piperine | Investigational | CYP3A4 | 1576 |
upregulated | piperine results in increased expression of CYP3A4 mRNA | 7q22.1 | |
| Piperine | Investigational | IL1B | 3553 |
downregulated | piperine results in decreased expression of IL1B mRNA | 2q14.1 | |
| Piperine | Investigational | IL6 | 3569 |
downregulated | piperine results in decreased expression of IL6 mRNA | 7p15.3 | |
| Piperine | Investigational | TNF | 7124 |
downregulated | piperine results in decreased expression of TNF mRNA | 6p21.33 | |
| Piperine | Investigational | UGDH | 7358 |
downregulated | piperine results in decreased expression of UGDH mRNA | 4p14 | |
| Piperine | Investigational | UTRN | 7402 |
upregulated | piperine results in increased expression of UTRN mRNA | 6q24.2 | |
| Piperonyl butoxide | Approved Vet Approved | CYP1A1 | 1543 |
upregulated | Piperonyl Butoxide results in increased expression of CYP1A1 mRNA | 15q24.1 | |
| Piperonyl butoxide | Approved Vet Approved | CYP1A2 | 1544 |
upregulated | Piperonyl Butoxide results in increased expression of CYP1A2 mRNA | 15q24.1 | |
| Piperonyl butoxide | Approved Vet Approved | PDCD4 | 27250 |
downregulated | Piperonyl Butoxide results in decreased expression of PDCD4 mRNA | 10q25.2 | |
| Piperonyl butoxide | Approved Vet Approved | PDCD4 | 27250 |
upregulated | Piperonyl Butoxide results in increased expression of PDCD4 mRNA | 10q25.2 | |
| Piperonyl butoxide | Approved Vet Approved | TNFAIP3 | 7128 |
upregulated | Piperonyl Butoxide results in increased expression of TNFAIP3 mRNA | 6q23.3 | |
| Piperonyl butoxide | Approved Vet Approved | TPD52 | 7163 |
downregulated | Piperonyl Butoxide results in decreased expression of TPD52 mRNA | 8q21.13 | |
| Pirfenidone | Approved Investigational | ACTA2 | 59 |
downregulated | pirfenidone results in decreased expression of ACTA2 mRNA | 10q23.31 | |
| Pirfenidone | Approved Investigational | COL1A1 | 1277 |
downregulated | pirfenidone results in decreased expression of COL1A1 mRNA | 17q21.33 | |